Cell Kinetic Analysis in Pediatric Brain and Spinal Tumors: A Study of 117 Cases with Ki-67 Quantitation and Flow Cytometry

References

• Young JL J., Miller R. W. Incidence of malignant tumors in U.S. children. J Pediatr 1975; 86: 254–58
   PubMed Web of Science ®Google Scholar
• Ahyai A., Spaar F. W. DNA and prognosis in meningiomas: A comparative cytological and fluorescence-cytophotometrical study of 71 tumors. Acta Neurochir (Wien) 1987; 87: 119–28
   Google Scholar
• Ahyai A., Hori A., Bockermann V., Burckhard R., Blech M., Evangelos M. Impulse cytophotometric DNA analysis in pituitary adenomas. Neurosurg Rev 1988; 11: 77–86
   Google Scholar
• Ahyai A. Flow cytometric analysis of cellular DNA content in human astrocytomas and oligodendrogliomas. Neurosurg Rev 1988; 11: 177–87
   Google Scholar
• Alvarez F., Roda J. M., PerezRomero M. P., Morales C., Sarmiento M. A., Blazquez M. G. Malignant and atypical meningiomas: A reappraisal of clinical, histological, and computed tomographic features. Neurosurgery 1987; 20: 688–94
   PubMed Web of Science ®Google Scholar
• Christov K., Zapryanov Z. Flow cytometry in brain tumors. I. Ploidy abnormalities. Neoplasma 1986; 33(1)49–55
   Google Scholar
• Coons S. W., Davis J. R., Way D. L. Correlation of DNA content and histology in prognosis of astrocytomas. Am J Clin Pathol 1988; 90: 289–93
   Google Scholar
• Coons S. W., Johnson P. C., Haskett D., Rider R. Flow cytometric analysis of deoxyribonucleic acid ploidy and proliferation in choroid plexus tumors. Neurosurgery 1992; 31: 850–6
   Google Scholar
• Danova M., Riccardi A., Mazzini G., et al. Ploidy and proliferative activity of human brain tumors. Oncology 1987; 44: 102–7
   Google Scholar
• Danova M., Giaretti W., Merlo F., et al. Prognostic significance of nuclear DNA content in human neuroepithelial tumors. Int J Cancer 1991; 48: 663–7
   Google Scholar
• Danova M., Riccardi A., Gaetani P., et al. Cell kinetics of human brain tumors: In vivo study with bromodeoxyuridine and flow cytometry. Eur J Cancer Clin Oncol 1988; 24: 873–80
   PubMedGoogle Scholar
• Deckert M., Reifenberger G., Wechsler W. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 1989; 115: 179–88
   Google Scholar
• De Reuck J., Sieben G., DeCoster W., Roels H., VanderEecken H. Cytophotometric DNA determination in human oligodendroglial tumors. Histopathology 1980; 4: 225–32
   Google Scholar
• Frederiksen P., Reske-Nielsen E., Bichel P. Flow cytometry in tumours of the brain. Acta Neuropathol 1978; 41: 13–21
   Google Scholar
• Germano I. M., Ito M., Cho K. G., Hoshino T., Davis R. L., Wilson C. B. Correlation of histopathological features and proliferative potential of gliomas. J Neurosurg 1989; 70: 701–6
   PubMed Web of Science ®Google Scholar
• Hoshino T., Prados M., Wilson C. B., Cho K. G., Lee K-S, Davis R. L. Prognostic implications of bromodeoxyuridine labeling index of human gliomas. J Neurosurg 1989; 71: 335–41
   PubMed Web of Science ®Google Scholar
• Ironside J. W., Battersby R. DE, Lawry J., Loomes R. S., Day C. A., Timperley W. R. DNA in meningioma tissues and explant cell cultures. J Neurosurg 1987; 66: 588–94
   PubMed Web of Science ®Google Scholar
• Jay V., Becker L. E. Brain tumors. Curr Opin Neurol Neurosurg 1990; 3: 934–42
   Google Scholar
• Jimenez O., Timms A., Quirke P., McLaughlin J. E. Prognosis in malignant glioma: A retrospective study of biopsy specimens by flow cytometry. Neuropathol Appl Neurobiol 1989; 15: 331–8
   PubMedGoogle Scholar
• Knosp E., Kitz K., Perneczky A. Proliferation activity in pituitary adenomas: Measurement by monoclonal antibody Ki-67. Neurosurgery 1989; 25: 927–30
   PubMed Web of Science ®Google Scholar
• Kros J. M., van Eden C. G., Vissers C. J., Mulder A. H., vander Kwast T. H. Prognostic relevance of DNA flow cytometry in oligodendroglioma. Cancer 1992; 69: 1791–8
   PubMed Web of Science ®Google Scholar
• Lehmann J., Krug H. Flow-through fluorocytophotometry of different brain tumors. Acta Neuropathol 1980; 49: 123–32
   PubMedGoogle Scholar
• May P. L., Broome J. C., Lawry J., Buxton R. A., Battersby RD E. The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material. J Neurosurg 1989; 71: 347–51
   PubMed Web of Science ®Google Scholar
• Mork L. J., Laerum O. D. Modal DNA content of human intracranial neoplasms studied by flow cytometry. J Neurosurg 1980; 53: 198–204
   PubMed Web of Science ®Google Scholar
• Nishizaki T., Orita T., Furutani Y., Ikeyama Y., Aoki H., Sasaki K. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors. J Neurosurg 1989; 70: 379–84
   PubMed Web of Science ®Google Scholar
• Nishizaki T., Orita T., Kajiwara K., et al. Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuoploidy with survival or recurrence in brain-tumor patients. J Neurosurg 1990; 73: 396–400
   Google Scholar
• Qualman S. J., Shannon B. T., Boesel C. P., Jacobs D., Jinkens C., Hayes J. Ploidy analysis and cerebrospinal fluid nephelometry as measures of clinical outcome in childhood choroid plexus neoplasia. Pathol Ann 1992; 27(Pt 1)305–20
   Google Scholar
• Salmon I., Kiss R., Dewitte O., et al. Histopathologic grading and DNA ploidy in relation to survival among 206 adult astrocytic tumor patients. Cancer 1992; 70: 538–46
   PubMed Web of Science ®Google Scholar
• Shepherd C. W., Scheithauer B. W., Gomez M. R., Altermatt H. J., Katzmann J. A. Subependymal giant cell astrocytoma: A clinical, pathological, and flow cytometric study. Neurosurgery 1991; 28: 864–8
   PubMed Web of Science ®Google Scholar
• Shibata T., Burger P. C. The use of monoclonal antibody Ki-67 in determination of the growth fraction in pediatric brain tumors. Childs Nerv Syst 1987; 3: 364–7
   PubMed Web of Science ®Google Scholar
• Shibuya M., Hoshino T., Ito S., et al. Meningiomas: Clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. Neurosurgery 1992; 30: 494–8
   PubMed Web of Science ®Google Scholar
• Shiraishi T. Cell kinetic analysis of brain tumors using the monoclonal antibody ki-67: In vitro and in situ study. Acta Med Okayama 1990; 44(4)187–201
   Google Scholar
• Siegers H. P., Zuber P., Hamou M-F, VanMelle G. D., Tribolet N. D. The implications of the heterogeneous distribution of ki-67 labelled cells in meningiomas. Br J Neurosurg 1989; 3: 101–8
   PubMedGoogle Scholar
• Spaar F. W., Blech M., Ahyai A. DNA-flow fluorescence—cytometry of ependymomas. Acta Neuropathol (Berl) 1986; 69: 153–60
   PubMedGoogle Scholar
• Spaar F. W., Ahyai A., Spaar U., Gazsó L., Zimmermann A. Flow-cytophotometry of nuclear DNA in biopsies of 45 human gliomas and after primary culture in vitro. Clin Neuropathol 1986; 5(4)157–75
   Google Scholar
• Spaar F-W, Spaar U. DNA in human glioblastomas. A flow-fluorescence cytometrical examination of 96 tumors. Neurosurg Rev 1990; 13: 123–39
   Google Scholar
• Tomita T., Das L., Radkowski M. A. Bone metastases of medulloblastoma in childhood; correlation with flow cytometric DNA analysis. J Neurooncology 1990; 8: 113–20
   PubMed Web of Science ®Google Scholar
• Yasue M., Tomita T., Engelhard H., Gonzalez-Crussi F., McLone D. G., Bauer K. D. Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg 1989; 70: 385–91
   PubMedGoogle Scholar
• Zaprianov Z., Christov K. Histological grading, DNA content, cell proliferation and survival of patients with astroglial tumors. Cytometry 1988; 9: 380–6
   PubMedGoogle Scholar
• Zuber P., Hamou M-F, DeTribolet N. Identification of proliferating cells in human gliomas using the monoclonal antibody ki-67. Neurosurgery 1988; 22(2)364–8
   Google Scholar
• Elias J. M. Immunohistopathology: A Practical Approach to Diagnosis. American Society of Clinical Pathologists, Chicago 1990
   Google Scholar
• Vindelov L. L. A detergent trypsin method for the preparation of nuclei for flow cytometric analysis. Cytometry 1983; 3: 323–7
   PubMedGoogle Scholar
• Rorke L. B., Gilles F. H., Davis R. L., Becker L. E. Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 1985; 65: 1869–86
   Google Scholar
• Hosokawa Y., Tsuchihashi Y., Okabe H., et al. Pleomorphic xanthoastrocytoma. Ultrastructural, immunohistochemical, and DNA cytofluorometric study of a case. Cancer 1991; 68: 853–9
   PubMed Web of Science ®Google Scholar
• Smith M. T., Ludwig C. L., Godfrey A. D., Armbrustmacher V. W. Grading of oligodendrogliomas. Cancer 1983; 52: 2107–14
   PubMed Web of Science ®Google Scholar
• Burger P. C., Rawlings C. E., Cox E. B., McLendon R. E., Schold S. C., Bullard D. E. Clinicopathological correlations in the oligodendroglioma. Cancer 1987; 59: 1345–52
   PubMed Web of Science ®Google Scholar
• Horie H., Etoh T., Maie M. Cytogenetic characteristics of a malignant rhabdoid tumor arising from the paravertebral region. Acta Pathol Jpn 1992; 42: 460–5
   Google Scholar
• Schmidt D., Leuschner I., Harms D., Sprenger E., Schafer H-J. Malignant rhabdoid tumor. A morphological and flow cytometric study. Pathol Res Pract 1989; 184: 202–10
   PubMed Web of Science ®Google Scholar
• Handgretinger R., Kimmig A., Koscielnak E. E. Establishment and characterization of a cell line (Wa-2) derived from an extrarenal rhabdoid tumor. Cancer Res 1990; 50: 2177–82
   Google Scholar